Mml Investors Services »

Crispr Therapeutics shares owned by Mml Investors Services

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mml Investors Services from 13F filings

Historical chart of Mml Investors Services investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mml Investors Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mml Investors Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $327k 5.0k 64.81
2024-06-30 $391k 7.2k 54.01
2024-03-31 $618k 9.1k 68.20
2023-12-31 $752k 12k 62.61
2023-09-30 $1.1M 25k 45.38
2023-06-30 $1.2M 21k 56.16
2022-12-31 $613k 15k 40.62
2022-09-30 $873k 13k 65.34
2022-06-30 $722k 12k 60.79
2022-03-31 $410k 6.5k 62.78
2021-12-31 $334k 4.4k 75.67
2021-09-30 $611k 5.5k 111.90
2021-06-30 $840k 5.2k 161.82
2021-03-31 $489k 4.0k 121.76
2020-12-31 $641k 4.2k 153.06